KRAS and p53 are the most common genetic alterations in PDAC associated with altered glycolysis, PPP, and oxidative stress metabolism leading to poor prognosis, chemoresistance, metastasis, and cancer progression (Liu et al. 2019). Here, TP53 is linked to cancer.